BioCardia (BCDA) CEO Peter Altman Buys 1,900 Shares

What Happened

• Peter Altman, President & CEO and a director of BioCardia, acquired 1,900 shares in an open-market purchase on 2026-09-23. The weighted-average price reported was $1.05 per share, for a total disclosed value of $1,995. This was a purchase (insider buy), which some investors view as a modestly bullish signal.

Key Details

• Transaction date: 2026-09-23 (filed same day).
• Transaction type/code: Open-market purchase (P).
• Shares purchased: 1,900; weighted-average price: $1.05; total value: $1,995.
• Footnote: Trades were executed at prices ranging from $1.04 to $1.08; $1.05 is the weighted average. The reporting person can provide a breakdown of shares at each price upon request.
• Shares owned after transaction: Not disclosed in the provided Form 4.
• Timeliness: Filing appears timely (transaction and report date are the same).

Context

• The purchase size/value is small relative to many insider trades, so it may have limited market impact. No options, gifts, or tax-withholding events are involved in this filing.